Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W21 AI workflow automation for customer support teams on Zendesk; $3.33M Greycroft/YC-backed improving agent handle time and first-contact resolution with no-code workflow builder competing with Forethought AI for enterprise support operations automation.
FlowEQ is a San Francisco-based AI workflow automation platform for customer support teams — backed by Y Combinator (W21) with $3.33 million in total funding from Greycroft and Y Combinator — providing enterprise customer service organizations using Zendesk and other helpdesk systems with intelligent process guidance, no-code workflow automation, and AI-driven decision support that improves agent efficiency and reduces handle time across technology, e-commerce, and financial services sectors. Founded in 2020, FlowEQ helps support teams standardize responses, reduce first-contact resolution failures, and automate routine decision workflows that would otherwise require agents to manually navigate multiple knowledge sources and policy documents.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.